A COVID-19 vaccine for babies and toddlers is another step closer after Australian regulators confirmed that a low dose of Spikevax Moderna is being evaluated.
There are currently no COVID-19 vaccines approved for children under four years of age, and children five years of age or older are given the Pfizer jab.
Spikevax is available for children over the age of six and Moderna Australia has applied to the Therapeutic Goods Administration to extend it to younger children.
The TGA on Friday confirmed that it is being evaluated using a low dose of Spikevax, 25 micrograms at 0.25ml, for children aged between six months and five years.
This is below 50 micrograms in 0.25ml measurements which is currently used for children aged six to 11 years.
Spikevax, an mRNA vaccine, uses a genetic code to allow the production of the spike coronavirus protein.
Immune cells then recognize the spike’s protein as foreign and begin to build an immune response against it.
Latest 24 Hour Data on COVID-19:
- NSW: 10,954 cases, 19 deaths, 1377 in hospitals, 58 in ICU
- VIC: 12,160 new cases, 22 deaths, 524 in hospitals, 24 in ICU
COVID jabs being evaluated for infants as young as six months Source link COVID jabs being evaluated for infants as young as six months